ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000274.1|Tetarimycin_3 # 1300 # 2109 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.717	BGC0000274.1|Tetarimycin_3 	1300	2109	-	Loose	400	26.5646	vanR gene in vanL cluster	39.29	3002927	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGAGTGAGCTGGTCGAGCGCACCGAGATGCTGCGACCAGAACCGGCGCAGGCGCTGGGCGCCCTACTGGACGTCCCCGTCCCGGACCTCGCCAGGGACGGGCTGCCCCTGCTGTGGCACTGGTTCTACCTGCTCGACCGGCCGGCGCAGGCCGACCTCGGCCCCGACGGTCACCCGGTCCGCGGCGCCATCTCCGCCCCGCCCGGTCACCGCCGCATGTGGGCGGGTGGCCGCGTCGCCACCCAGGGGCCCCTGCGGTGTGGCGAGCAGGCCACCCGGCGCTCGGAAGTCCTGTCCGTGCGGGAGAAGCAGGGCCGGTCCGGGCCGCTGACCTTCGTCGTGGTCCGGCACCAGATCATCCAGAACGGACAGCTGGTCGTGCAGGAGGAGCAGGACATCGTCCACCGGGCGCCGGCCCCACTGTCCATACCGGACGCCGGACCGGTCGTCCCACCCGCCGGCGACGAGTGGGCGATCGACATCACCCCGACGCTGCTGTTCCGCTTCTCCGCACTCACCTACAACGCCCACCGCATCCACTACGACCGGGACTACGCCCGTGACGTCGAGGGTTACCCCGGCCTGCTGACCCACGGCCCGCTCCAGGCGCTCGCGATGGTCGAGGCCGCCCGTGCTCGAGGCGAGACGGGTGTCCGGCACTTCGAGTACCGGCTCGTCGCGCCCCTGTTCGACCACCAGGGCATGGTCGTCCGTGCGGACTCGGTGCGGGACATCCACGGCCGTCAGACCGCGACCGGGCGCTATGGTCATCGCCGTGATCGACAACGGCTACTGGACACTGCCGGCTGA	MSELVERTEMLRPEPAQALGALLDVPVPDLARDGLPLLWHWFYLLDRPAQADLGPDGHPVRGAISAPPGHRRMWAGGRVATQGPLRCGEQATRRSEVLSVREKQGRSGPLTFVVVRHQIIQNGQLVVQEEQDIVHRAPAPLSIPDAGPVVPPAGDEWAIDITPTLLFRFSALTYNAHRIHYDRDYARDVEGYPGLLTHGPLQALAMVEAARARGETGVRHFEYRLVAPLFDHQGMVVRADSVRDIHGRQTATGRYGHRRDRQRLLDTAG	MTDRIVVVDDEQEIANLITTFLENEGFQVTTFYKGEDFLTYIARESISLAILDVMLPDIDGFRILQEIRKNFYFPVLMLTAKEENMDKIMGLTLGADDYITKPFNPIEVVARVKTQLRRVQKYNRKVENESVIEFNKDGLTLKKDSHQVFLFDKEITVTPIEFNLLLYLFEHQGVVVSSEELFEAVWKEKYLENNNTIMAHIARLREKLDEQPRKPKFIKTVWGVGYIIEK	116.45	gnl|BL_ORD_ID|455|hsp_num:0	409			462	546	vancomycin
BGC0000274.1|Tetarimycin_5 # 3356 # 4507 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0000274.1|Tetarimycin_5 	3356	4507	-	Loose	1800	26.1794	MexD	33.33	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGATGGGCTCAGCACGGACGAAGCCGCGATCGTCTCGGTGGTGGCCGAGTTCGTCGACCGGGAGGTGCGGCCGGTCGCGCGGGAGCTCGAGCACGCGAACACCTACCCGGAGAAGCTCGTCGAGCAGATGAAGGAGCTGGGTGTCTTCGGGCTGGCGATCCCGGAACCGTGGGGCGCGGCGAAGGTGTCGGCGCAGTGCTACGCCGCGGTGACCGAGGAGCTGGCCCGGGGCTGGATGAGCCTGGCCGGCGCCATGGGCGGGCACACCGTGGTCGCCAAGCTCCTCGTCGACCACGGCACGGACGAGCAGAAGGACCGGTACCTGCCGCGGCTGGCCACCGGGGAGGTCCGGGCGACGATGGCGTTGACCGAGCCGGGCGGCGGGTCCGACCTGCAGGCCCTGCGCACCACCGCGCGCCGCGACGGTGAGTCCTATGTGGTCAACGGGTCGAAGACGTGGATCACCAACGCGCGCCGGTCCCAGCTCGTCGCCGTGCTGTGCAAGACGGATCCCGCTGCCGAGCCCGCGCACACGGGCATGAGCGTGCTGCTCATGGAGAAGGGGCCGGGCTTCCACGTGTCGCGGGACCTGCCGAAGCTGGGGTACAAGGGCGTGGAGAGCTGCGAGCTGTCCTTCGACGACGTCCGGGTGCCGGCGTCGGCGTTGCTCGGTGGTGTGCCGGGCAAGGGTTTCGCGCAGATGATGCGTGGCCTGGAGATCGGCCGGATCCAGGTCGCCGGCCGCGCGCTCGGGGTGGCGCGGGCCGCGCTGGAGGACTCGCTGCGGTACGCGCAGGAGCGGGAGAGTTTCGGCAAACCGATCTGGCAGCACCAGTCGGTCGGCAACCACCTCGCCGACATGGCGACGAAGCTGGAGGCGGCCCGGCAGCTCACGCACTACGCCGCCCGCCGCTACGACTCCGGCGCCCGCGCGGACATGGAGGCGGGCATGGCGAAGCTGTTCGCGTCGGAGGTGGCGATGGAGGTCGCGTTGAACGCGGTGCGGGTCCACGGCGGTTACGGCTACTCGACCGAGTTCGACGTCGAGCGGTACTTCCGGGACGCACCGCTGATGATCGTGGGTGAGGGCACCAACGAGATCCAGCGCACCGTGATCGCCCGCCAGCTGGTGAAGCGGTACCCGAGGTGA	MDGLSTDEAAIVSVVAEFVDREVRPVARELEHANTYPEKLVEQMKELGVFGLAIPEPWGAAKVSAQCYAAVTEELARGWMSLAGAMGGHTVVAKLLVDHGTDEQKDRYLPRLATGEVRATMALTEPGGGSDLQALRTTARRDGESYVVNGSKTWITNARRSQLVAVLCKTDPAAEPAHTGMSVLLMEKGPGFHVSRDLPKLGYKGVESCELSFDDVRVPASALLGGVPGKGFAQMMRGLEIGRIQVAGRALGVARAALEDSLRYAQERESFGKPIWQHQSVGNHLADMATKLEAARQLTHYAARRYDSGARADMEAGMAKLFASEVAMEVALNAVRVHGGYGYSTEFDVERYFRDAPLMIVGEGTNEIQRTVIARQLVKRYPR	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	36.72	gnl|BL_ORD_ID|1485|hsp_num:0	1523			465	630	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000274.1|Tetarimycin_7 # 5862 # 6881 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.699	BGC0000274.1|Tetarimycin_7 	5862	6881	+	Loose	550	26.1794	AAK-1	35.09	3006863	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	AAK beta-lactamase	ATGTTCACGATCACAAGGAACGGACTGCTCGCCGGCGTGCTGGCGGCGGCCGCGCTGCTGGTGGCACCACCGGCGGCGACGGGCGACGTCGCGGTCCAGGCCGACCCCGTGCGGGTGATGCCGCTCGGCGACTCGATCACCGACGGGTTCAACGTGCCCGGCGGCTACCGCATCGACCTGTGGCAGAAGATCGTCGCCGGCGGCCGGTCCGCCGACTTCGTCGGCTCGCAGACCAACGGCCCCGGCAACCTCGGCGACCGCAACCACGAGGGGCACTCGGGCTGGACCATCGCGCAGATCGACGCCAACATCGTCAACTGGCTGCGCACGTTCACACCGAGGACCGTCCTGCTGCACATCGGCACCAACGACATGTACGGCAGCGACCCCGCCGGCGCACCGGCGCGACTGTCCACCCTGATCGACCGCATCACCACGACCGCACCGAACGCGGACGTGTTCGTCGCGACGATCGTCCCGATCTCGTTCGCGGACCAGACCGTGCGCACGTTCAACGCGACGATCCCGGGCATCGTGCAGAGCAAGGTCAACGCCGGCAAGCGGGTACACCTCGTGGACATGTACCGGGCCCTCACCACGGCCGACCTCGCCGACGGCGTGCACCCCAACGCCGGCGGCTACAGCAAGATGGCCACCACCTGGTACAACGCCCTGCTGTCGGTACCGGGCAGCATCGGCGACCCGACCCAGGAACCCCCACCCACGGGCACCTGCGCCGCGACGGCCAGCGTGGTCAACACGTGGAACGGCGGCTACCAGGCCGATGTGAGCGTGCGCAACAACACCTCCACCCACCTCACCGGCTGGACGGTGTCCCTCACCCTGGCCAACGGCCAGACGATCACCAACCTGTGGGGCGCGGTCCCCGCGAGCACCGGCACGGTGAAGAACGCGGCGTACAACGGAACCGTCACCGGCGGCGGCACGACGACGTTCGGCTTCGTCGCCTCCGGCCCCGGCACCCCGTCGGTGACCACCACGTCCTGCACCAGCCCGTGA	MFTITRNGLLAGVLAAAALLVAPPAATGDVAVQADPVRVMPLGDSITDGFNVPGGYRIDLWQKIVAGGRSADFVGSQTNGPGNLGDRNHEGHSGWTIAQIDANIVNWLRTFTPRTVLLHIGTNDMYGSDPAGAPARLSTLIDRITTTAPNADVFVATIVPISFADQTVRTFNATIPGIVQSKVNAGKRVHLVDMYRALTTADLADGVHPNAGGYSKMATTWYNALLSVPGSIGDPTQEPPPTGTCAATASVVNTWNGGYQADVSVRNNTSTHLTGWTVSLTLANGQTITNLWGAVPASTGTVKNAAYNGTVTGGGTTTFGFVASGPGTPSVTTTSCTSP	MRYIRLCIISLFATLPLAVHASPQPLQQITLRESQLSGRVGTIEMDLASGRTLTAWRADQRFPIMRTFTVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMPVGELCAAAITISDTSAANLLLATVGGPAGFTAFLRQIGDNVTRLHRWETELHAALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLLRSVLPAGWFIADKTGAGERGARGIVALLGPNHKAERIVVIYLRDTPASMAERNQQIAGIGAALLEHWQQ	118.53	gnl|BL_ORD_ID|3091|hsp_num:0	4122			171	339	
BGC0000274.1|Tetarimycin_8 # 6907 # 8376 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.723	BGC0000274.1|Tetarimycin_8 	6907	8376	-	Loose	275	25.409	AAC(6')-Iw	29.09	3002567	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGCTCGACGGGACCGGCGGTGATGCTGCGAACGTGGACGTTCCGAAGCAGCTGTTCATCGATGGTGCCTGGGTCGACGCCGAGGGCGGGGCCGTCATGGCGGTGGACGACCCGGCGACCGGGGACGTCGTCTGCCACGTCGCGGACGCCGGGCCGAAGGACGCGCTCCTCGCCGAGGAGGCGGCGGTCCGGGCGCAGGAGGGTTGGGCGGCCACGGCGCCGAGGGCCCGCAGCGAGGTCCTGCGCCGCGCCTACGAGATCGTCATCGAGCGCACCGACGACCTGGCGCTGCTGATGACCACCGAGATGGGCAAGCCGCTCGCCGAGGCCAGGGGCGAGGTCGCCTACGCGGCCGAGTTCTTCCGCTGGTTCTCCGAGGAGGCGGTGCGGATCGACGGCGGGTTCGGTGTCCTGCCGGACGGTCGCAACCGGATGTTGCTGATGCGCCGGCCGGTCGGCCCCAGCCTGCTGATCACCCCGTGGAACTTCCCGCTCGCCATGGGCACGCGCAAGATCGGGCCCGCGCTCGCGGCCGGCTGCACCGCCGTGCTCAAGCCCGCTCCGCAGACCCCGCTGTCCAGCCTGGCGCTCGCGGGCATCCTGGCCGAGGCGGGCCTGCCGGACGGCGTCCTCAACGTCGTGACGACCTCGAGGGCCGGCGAGGTCGTCGAGCCGCTGCTGCGCGGCGGCCGGATCCGCAAGCTCTCCTTCACCGGTTCCACGCAGGTCGGCAAGCTGCTGCTGGCCCAGTGCGCCGACACCGTCGTGCGCACGTCCATGGAGCTGGGCGGCAACGCCCCGTTCATCGTGTTCGAGGACGCGGACCTCGACGTCGCGGTCGACAGCGCGATGACGGCCAAGATGCGCAACATGGGCGAGGCGTGCACCGCCGCCAACCGCTTCTTCGTCCACCGGTCCGTGGCCGACGAGTTCGCCCGCCGGCTCGCGGAACGCATGGGCTCGCTCGTCGTCGGCCCTGGTACCCAGCCGGGCGTCGACGTGGGCCCGCTGATCGACCTGACCGGCCGGCGCAAGGTGGAGCGGCTGGTCGAGGACGCCGTCCAACGCGGCGCCACGGTCCTCGTCGGCGGCACGACCCCGACGGGCCCCGGCTCCTTCTACCCACCGACCGTGCTGGCCCGCGTCTCCCCGGACAGCGACCTCATGTCCACGGAGATCTTCGGCCCGGTAGCGGCCATCCTGACCTTCGACGACGATGACGAGGCCGTACGCCGCGCCAACGACACCGACTGGGGCCTGGTGAGCTACGTGTTCACCGAGTCCCTCGACCGCGCACTGCGGGTCAGCGACCGCCTGGAGGCCGGCATGGTGGGCCTGAACACCGGCCTCGTCTCCAACCCGGCCGCCCCGTTCGGCGGCGTCAAGCAGTCCGGCCTCGGACGGGAGGGCGGCCGGGTCGGCATCGACGAGTTCCTGGAGTACAAGTACGTGGCGGTGCCGGTGCGCTGA	MLDGTGGDAANVDVPKQLFIDGAWVDAEGGAVMAVDDPATGDVVCHVADAGPKDALLAEEAAVRAQEGWAATAPRARSEVLRRAYEIVIERTDDLALLMTTEMGKPLAEARGEVAYAAEFFRWFSEEAVRIDGGFGVLPDGRNRMLLMRRPVGPSLLITPWNFPLAMGTRKIGPALAAGCTAVLKPAPQTPLSSLALAGILAEAGLPDGVLNVVTTSRAGEVVEPLLRGGRIRKLSFTGSTQVGKLLLAQCADTVVRTSMELGGNAPFIVFEDADLDVAVDSAMTAKMRNMGEACTAANRFFVHRSVADEFARRLAERMGSLVVGPGTQPGVDVGPLIDLTGRRKVERLVEDAVQRGATVLVGGTTPTGPGSFYPPTVLARVSPDSDLMSTEIFGPVAAILTFDDDDEAVRRANDTDWGLVSYVFTESLDRALRVSDRLEAGMVGLNTGLVSNPAAPFGGVKQSGLGREGGRVGIDEFLEYKYVAVPVR	MKIMPISEALLADWLQLRILLWPDHEDAHLLEMRQLLTRTDSLQLLAYSETQQPIAMLEASIRHEYVNGTQTSPVAFLEGIYVLPEHRRSGIATQLVQQVEQWAKQYACTEFASDAAIDNTISHAMHQALGFHETERVVYFKKNIS	334.93	gnl|BL_ORD_ID|1167|hsp_num:0	1271			105	264	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000274.1|Tetarimycin_9 # 8421 # 9164 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.711	BGC0000274.1|Tetarimycin_9 	8421	9164	-	Loose	550	30.8018	RlmA(II)	30.99	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGACCGATCTCTTCGACGCGGGAGCGATGTACGACGAGGACTACCTCCGGCTCTTCGCCGTGCCGTTCGCCGAGGACCCGCGCAGTGACGCGGATGCCGAGCTGATCTGGGGGCTCGCCGGGCCGCGGCCCGGTACCCGGGTGCTGGACCTCGCGTGCGGGCACGGCCGGATCGCCAACCGGCTGGCCGCTCGCGGTTGTGAGGTCACCGGGCTCGACTCGTCGGCGGTGTTCCTGGAGCGGGCGCGTGCCGACGCCGAGGAGCTGGGCGTCGAGGTCGACTACGTCGCCGGTGACCTCCGCGAGCTGCCGTGGACGGACCGGTTCGACCTGGTGGTCAACTGGGCCACGGCGTTCGGCTACTTCGACGACGACGTCAACCGGGACGTGCTGAGGCAGGTCCGGCGTGCGTTGCGGCCAGGTGGCCAGCTGGTGATGGACCTCAACAACCTCGTCGCCCGGCTGCGTGGTTACCAGCCGTCGCACGTCGAGGCACATGGGAGCGGTGACCTGCGGGTCGACCGGTTCCACCTCGAACCGCTGACGAACCGGCTCGAGGTGGAACGGACGATCGTCCGGGACGGGTCGGCCAGGACACTGTCGTTCGTCGTCCGGCTGTTCGGCTTCCCCGAGATCAGGGACTGGCTGCTCGCGGCCGGCTTCACCGCGGTGGCCGGCCACGGCGAGGACGGCGCCCCGCTCGCGGCGGAGCACGACCGGATGGTGCTGCACGCCCGCACTTGA	MTDLFDAGAMYDEDYLRLFAVPFAEDPRSDADAELIWGLAGPRPGTRVLDLACGHGRIANRLAARGCEVTGLDSSAVFLERARADAEELGVEVDYVAGDLRELPWTDRFDLVVNWATAFGYFDDDVNRDVLRQVRRALRPGGQLVMDLNNLVARLRGYQPSHVEAHGSGDLRVDRFHLEPLTNRLEVERTIVRDGSARTLSFVVRLFGFPEIRDWLLAAGFTAVAGHGEDGAPLAAEHDRMVLHART	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	87.59	gnl|BL_ORD_ID|2052|hsp_num:0	2274			267	474	tylosin; mycinamicin
BGC0000274.1|Tetarimycin_10 # 9248 # 10219 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.727	BGC0000274.1|Tetarimycin_10 	9248	10219	+	Loose	200	54.299	Escherichia coli soxS with mutation conferring antibiotic resistance	29.59	3003511	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	GTGACGGCGCAACTGGGAGTCGGGCGACTCGTCGTGGTGGTGTTCGACGGTGTGTCGATGGGGATCATGTCGTTCGCGTTCGGGGTGTTCGACATGGCCGTGGCCTACGGCGAGCTGGACGGGCTCGACGTGCGGGTGGTGGCCGGTGAGCCGGGGGCGACGCTGGTCGGTGGGGGGCTGCGGCCCGCGGTGCCGTACGACCTGGCCGCGATCCGCGATGCCGACCTGGTCATCGTGCCCAACTGGCGGTCGCCGGGGGAGCTGCCGCCCGAGGAGGTGCTCGAGGCGTTGCGGGTCGCGCACGCGCGTGGCGCCAAGGTGGCCGGGCTGTGCAGCGGGGTGTTCGTGGTCGCCGCCGCCGGGTTGCTGGACGATCGGCCGGCCACCACGCACTGGGCGGCCGCCGGGTTGCTCGCACAGCTGTACCCGAAGGTCGACGTGCGGGAGTCGGTGCTCTACGTCGATGACGGTGACGTGCTCACCGCGGGTGGTGGTGCGGCGGGGATGGACCTCGGCCTGCACCTGATCCGGCTCATGGCGGGGGCCGAGGTGGCCAACCGGCTCGCGCGGAGCATGGTCGTGCCGCCGCACCGGCCGGGTGGGCAGGCGCAGTACATCTCCTCGCCGGTGCCGGAGCCGGACGAGACCGACCCGGTCGGTGAGACGATCAGCTGGGCGCTCACCCGGCTCGACCAGCTGCTCCCCGTCGACGAGCTGGCCAGGCACGCCAACATGAGCCGGCGCAACTTCGACCGGCGGTTCCGGGAGATCACCGGTGCCACGCCGGCGAACTGGCTGACCCACCAGCGGGTCATCCGGGCGCAGCAGCTGCTCGAGTCCACGGAGCTGCCGGTGGACCAGATCGCCCGTTACTGCGGGTTCTCCTCCGCCGCCGCGCTGCGGCCGCACTTCCGCCGGCTGGTCGGGGTGCCGCCGGCGTCGTACCGGGAGACGTTCGGCACCGTGTCCTGA	VTAQLGVGRLVVVVFDGVSMGIMSFAFGVFDMAVAYGELDGLDVRVVAGEPGATLVGGGLRPAVPYDLAAIRDADLVIVPNWRSPGELPPEEVLEALRVAHARGAKVAGLCSGVFVVAAAGLLDDRPATTHWAAAGLLAQLYPKVDVRESVLYVDDGDVLTAGGGAAGMDLGLHLIRLMAGAEVANRLARSMVVPPHRPGGQAQYISSPVPEPDETDPVGETISWALTRLDQLLPVDELARHANMSRRNFDRRFREITGATPANWLTHQRVIRAQQLLESTELPVDQIARYCGFSSAAALRPHFRRLVGVPPASYRETFGTVS	MSHQKIIQDLIAWIDEHIDQPLNIDVVAKKSGYSKWYLQRMFRTVTHQTLGDYIRQRRLLLAAVELRTTERPIFDIAMDLGYVSQQTFSRVFRRQFDRTPSDYRHRL	301.87	gnl|BL_ORD_ID|1975|hsp_num:0	2066			18	312	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan; enrofloxacin
BGC0000274.1|Tetarimycin_11 # 10284 # 11435 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000274.1|Tetarimycin_11 	10284	11435	+	Loose	400	28.4906	salC	57.14	3007027	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGAGCGACAAGGAAATCCGACCGTTCCACATCGACATCCCGCAGTCCGAGCTGGACGACCTCCGGGACCGGCTGGCCAGGACCCGCTGGTCCGGCGGCGAGCTGCCCGGCGCCGGCTGGCGCCACGGCGTCCCGCAGGACGAGCTGCGGACCCTCGTCGAGTACTGGGCGGACGGCTACGACTGGCGCGCCCACGAGGCCCGCATCAACGCCTACCCGCAGTTCGTCACCGAGATCGACGGCACGACCGTCCACTTCCTGCACGTGCGCTCACCGGAACCGGACGCGTTCCCGCTGGTGCTCACCCACGGCTGGCCCGGCACGTTCTACGAGTACCTGGACGTGATCGACCAGCTGACCAACCCGCGTGCGCACGGCGGTGACCCGGCGAACGCGTTCCACCTGGTCATCCCGTCCATCCCGGGGTTCGCGTTCTCCGGTCCCACCCAGGAGACCGGCTGGGACACGACACGGGTCGCCCGCGCGTGGCTGGAGCTGATGAGCCGCCTCGGCTACGACCGGTTCGGTGCGGCCGGCAGCGACAAGGGTTCGCTGATCTCCCCGGCCCTGGGCCAGCTCGCCCCGGACCGCGTCACGGCGGTGCACGTGGCCCAGGTGTTCGCGTTCCCATCCGGTGACCCGGCCGAGTTCGAGGGTTTCGGCCCGGAGGAGTACCGCCGGCTGGAGTTCATGCAGCGGTTCGAGAACGAGCACTCCGGCTTCAACAAGATCCAGGGCATGCGCCCGGCCACGCTCACGCACGCACTGGCCGACTCACCCGCGGGCCTGCTCGCGTGGGTCCTCGACCCGATGCGCGGCTTCGGCGACCACTCGGCTGAGGTGGACGAGCGGCTCGACGCCGACTTCGTGCTGACCGTGGCGTCGTTGTTCTGGCTGACGGACACGATCGGGTCGGCGGCACGTTCCTACTACGAGGACATGCACGCCGCGCACGAGGAGACCGACCGGAGCGAGGTGCCGACCGGCGTCGCGGTGTTCGCGAGCGACTTCCCGTCGATCCGCGCCTTCGCCGAGCGGGACAACACGATCGTGCACTGGTCGGAGTTCGACCGCGGTGGCCACTTCTCCGGCACCGACGCACCCGACCTGCTGAGCCGCGACCTCGGTGACTTCTTCCGGAAGTACCGGTGA	MSDKEIRPFHIDIPQSELDDLRDRLARTRWSGGELPGAGWRHGVPQDELRTLVEYWADGYDWRAHEARINAYPQFVTEIDGTTVHFLHVRSPEPDAFPLVLTHGWPGTFYEYLDVIDQLTNPRAHGGDPANAFHLVIPSIPGFAFSGPTQETGWDTTRVARAWLELMSRLGYDRFGAAGSDKGSLISPALGQLAPDRVTAVHVAQVFAFPSGDPAEFEGFGPEEYRRLEFMQRFENEHSGFNKIQGMRPATLTHALADSPAGLLAWVLDPMRGFGDHSAEVDERLDADFVLTVASLFWLTDTIGSAARSYYEDMHAAHEETDRSEVPTGVAVFASDFPSIRAFAERDNTIVHWSEFDRGGHFSGTDAPDLLSRDLGDFFRKYR	MLFLFEKKSLEIDNKLLIPSLTFIIEENEHLAIVGINGIGKSTLLNKIHHKENIETAMMEQDLTKYGTLNVMEYIMLTYPQLSSLRENLSDLDNINRYIELDGYEIEQNIIIEGKKLGLTERHFDQLISTLSGGEQTKVSFLKVKLDKARLLLIDEPTNHMDEEMKVWLTNAFKQEKRAILFVSHDKTFLNETPDAILELSSSGATKYSGQYDNYKQQKDLEYKTIKLQYEKQEKEQRAIEETIKKYKEWYQKASQKASVRNPYQQKQLSKLAKKFKSKEYQMNKKLEQTNLSDPEEEGKTFSMQHHAFKSHYLVKFKNVTFSYNEKPIFNDVSFHIKRNQNVIIEGQNGSGKSTLIKLILGQLTPDEGEVIVHPELEIGYFSQDFNNLNMKNTVLEEIMSIQEMKEAEARTILANYYFNENRINDVVANLSMGEKCRIQFVKLYFSNPHILILDEPTNYFDIEMQEKIIQLIQSFQGSTLIISHDKYFKEKLKDQIWTIKNLDLVHENLKIENPLNADSIKNQLNELEQYTDERNRETEF	70.79	gnl|BL_ORD_ID|4726|hsp_num:0	5738			1038	1101	lincomycin; clindamycin; virginiamycin M1; tiamulin; retapamulin
BGC0000274.1|Tetarimycin_12 # 11519 # 12025 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.716	BGC0000274.1|Tetarimycin_12 	11519	12025	+	Loose	700	25.7942	ACT-66	33.33	3006261	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGTGTTGCGCCCGTTCCGCTTCGGCCTCGTCCAGCCGGGACAGGAACCCCAGGAGGATGAGCACCTCCCGGGAGTCGACGTCGGCGCGGATCGTCCCCTCCCCCCTGCCCGCTTCGAGCAGGAGGTCGATGGCCTCGCCGATAGACCTCCGTCAGGAGTGCCTCACGGGTCGGGAAGTTGCGGTAGAGCGTGCCCTGTCCGACGCCGGCGGCCTTCGCGACCGCCTTCATCTGCAGCTCCGACGTCGAGCTCAGCAGTTCACGAGCGGTCCGCAGGATGCGGGCTCGGTTGCTGAGCGCTGTGTGCCACACGACCCCGTCACCGGCAAGACGGTCATCGTCACGGGCGCGAGCAGTGGCATCGGGCGGGAGATCGCCGGCATGCTCGCGCGCCGCGGTGCCTCGGTGGTGCTCGCCGCGCGGCGCCGGGAGCGCATCGACGCCCTCGCGGGGTCGATCGCCGAAGCGGGTGGCCGGCGATCGCCGTGCGGACCGACGTCGCGGTGA	MCCARSASASSSRDRNPRRMSTSRESTSARIVPSPLPASSRRSMASPIDLRQECLTGREVAVERALSDAGGLRDRLHLQLRRRAQQFTSGPQDAGSVAERCVPHDPVTGKTVIVTGASSGIGREIAGMLARRGASVVLAARRRERIDALAGSIAEAGGRRSPCGPTSR	MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLHFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQFGIVMLANKSYPNPARVEAAYHILDALQ	44.09	gnl|BL_ORD_ID|3119|hsp_num:0	4157			951	1086	
BGC0000274.1|Tetarimycin_13 # 12568 # 13569 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0000274.1|Tetarimycin_13 	12568	13569	-	Loose	500	34.2686	chrB	41.51	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGACCGCCGACGTCACCGCGGCGAGCACGGTCGTCGAGCTGATCACCGGCGGGTGGCGGGCGCAGGCCGTCCACACCGCGGTGAAACTGCGCCTGCCCGACCACGTCGAGGCGGGCCACACGACGGACGCCGCGCTGGCCGCGGCGTCGGGTGCGGAGGAGGACGGCATCCACCGCCTGATGCGGCTGCTCGTGGCCGTCGGCGTGTTCGCCGGTGACGGCGGTGGCGGTTACCGCACCACGGACGTGAGCCGGGCCCTGCTGGACCGGCCCGGCTCACAACGTGACATGTGCCTGCTCTACGGCGAGGAGTTCTACGCCGCGTGGGGCCACGCCGTCGAGGCGATCAGCACGCTCGGCTCCGGGTTCGAGCTGGCCCACGGCACGCCGGTCTACGCCTACTTCACGGCGGATCCCGAGCGCACGAGGAAGTTCCAGGGCGCCATGCGCGCGACGAACCTGTTCTTCGGCGCGGTGCCCGGCGTGTTCGACTTCGCCGGCAAACGGGTGGTCGACCTGGGCGGCGGCTCGGGCCAGCTGCTCGGCGAGATCCTCACCGCGACCCCGTCCGCCCGAGGCGTGCTGCTGGACCTGCCGAACGTGGTCGCGGCGGCCCGCGAGCACCTCGCCGGCCTCGCGGACCGGGTGGAGCTGGTCGGCGGCGACATGTTCGCGTCGGTACCGCCCGGCGGCGACGTGTACCTCCTGTGCCGGGTACTGGCCGGCCACTCCGACGACGCGGTGGTGGAGCTGTTCACCACCATCCGCGACAACCTGGCCACCTCGTCGGCCCGGCTGCTGCTGCTCGACCGCCTGGTCGTCGACGAGGGCTCCACCGTGCTGCCGGCGCAGTGGGACCTGCACCTGCTGATGACCACCGGCGGCCGGCACCGCTCGCTCGCGGAGCTGCGGACGCTGCTGGAGCGGGCGGGCCTGGAGATCGAACGGGCCGAGGACCTGCCGGTGGAGACCACGGCGCTCGTGGTCCGGCCGCGAACGTAG	MTADVTAASTVVELITGGWRAQAVHTAVKLRLPDHVEAGHTTDAALAAASGAEEDGIHRLMRLLVAVGVFAGDGGGGYRTTDVSRALLDRPGSQRDMCLLYGEEFYAAWGHAVEAISTLGSGFELAHGTPVYAYFTADPERTRKFQGAMRATNLFFGAVPGVFDFAGKRVVDLGGGSGQLLGEILTATPSARGVLLDLPNVVAAAREHLAGLADRVELVGGDMFASVPPGGDVYLLCRVLAGHSDDAVVELFTTIRDNLATSSARLLLLDRLVVDEGSTVLPAQWDLHLLMTTGGRHRSLAELRTLLERAGLEIERAEDLPVETTALVVRPRT	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	118.93	gnl|BL_ORD_ID|274|hsp_num:0	305			261	399	tylosin; chalcomycin; mycinamicin
BGC0000274.1|Tetarimycin_14 # 13566 # 14051 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.642	BGC0000274.1|Tetarimycin_14 	13566	14051	-	Loose	420	24.6386	catII from Escherichia coli K-12	28.57	3004656	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGATTGGCGAGGTAATGACCACATTTGACCAGAAAGCGGAATTGCGGCGCCAGAACCGAGCCGTGGTGGAGGACTACATGAGCCGCCAGGGCGAGGGCCGGCTGACCCGCTACCAGCTTTTCACGGAGGACGGCAGTGGCGGGCTCTACACCGGCGACACGCAGGAGCCGATCATCTCGGTGGGCCGCGAGAAGCTGAAGGCGCACGGTGCGTGGTCGCTGCGGATCTTCCCGGACTGGGTCTGGTACAACGTGGAGATCTTCGAGACGCAGGACCCGAACCGGTTCTGGGTGGAGTGCGACGGCAGGGGCAAGATCCTGTTCCCGGACTACCCGCCCGGCTACTACGAGAACCACTTCATCCACGCGTTCCGCTTCCGGGACGGCAGGATCTGCGAGCAGCGCGAGTTCATGAACCCGTACCACCAGATGCGTGCCCTCGGCATCGACATCCCGGTGATCAGGCGGGCCGGGATCCCCACGTGA	MIGEVMTTFDQKAELRRQNRAVVEDYMSRQGEGRLTRYQLFTEDGSGGLYTGDTQEPIISVGREKLKAHGAWSLRIFPDWVWYNVEIFETQDPNRFWVECDGRGKILFPDYPPGYYENHFIHAFRFRDGRICEQREFMNPYHQMRALGIDIPVIRRAGIPT	MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAETGYKFYPLMIYLISRAVNQFPEFRMALKDNELIYWDQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTAEYQHDTRLFPQGNLPENHLNISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVLLPVSVQVHHAVCDGFHAARFINTLQLMCDNILK	75.59	gnl|BL_ORD_ID|2197|hsp_num:0	3355			240	387	chloramphenicol
BGC0000274.1|Tetarimycin_15 # 14073 # 14384 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.696	BGC0000274.1|Tetarimycin_15 	14073	14384	-	Loose	500	25.0238	MYO-1	32.0	3006954	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MYO beta-lactamase	ATGCGCGCGGTCATCGCCTGGTGGGATCTGGGCGACTCGGACCAGACCATCGACTCACTGCGTGACCACCTCGGCACCGAGGGCGTGACGCAGTGGACCAAGGTTCCCGGCCTGCGCCTGAAGATCTGGCTCTCCGACCGCCCCGGGAACCGGTGGGGCGGGGCCATGCTGTGGGACCACGGACATCCCGCCGAGGGACAGGCGCTGCCACCGAACCGGGCCACCGAGCTGATCGGCTACCCGCCGACGGAGCGGGTCGAGTTCGACATCGAGGTCGTCGTCGAGGCCGGCACCGCCCGGATTTGTTCCTGA	MRAVIAWWDLGDSDQTIDSLRDHLGTEGVTQWTKVPGLRLKIWLSDRPGNRWGGAMLWDHGHPAEGQALPPNRATELIGYPPTERVEFDIEVVVEAGTARICS	MKILLAFFLLSSLTFISCKESSSNHNQANQENKKEIINKPLTDSLIVYQTENLIINKLSNHIYEHISFLNTDDFGKVACNGMLVLNENKVVVFDTPTDDKSSLELINFVTNTLKSEIIGLIPTHFHDDCIGGITEFENHNIQTYVSKETIELLKDNGQEFSNPTKDFDNSLTLDIGNKKVYAEYFGEGHTKDNVVGYFPEDNAVFGGCLIKEIDASKGYLGDANIKEWSTTVEKVKLKYPNAKIVIPGHGKWGGIELFDYTIKLFE	38.72	gnl|BL_ORD_ID|3706|hsp_num:0	4776			630	780	
BGC0000274.1|Tetarimycin_16 # 14406 # 15026 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000274.1|Tetarimycin_16 	14406	15026	-	Loose	400	24.2534	IMP-53	50.0	3005463	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGGGAATCCCGCCGATCCCGGCCTACCCGCTGCCGGGCGCGAGCGAGCTGCCCGACAACGTCGCGACCTGGCAGCCGGACCCGGACCGGGCCGTCCTGCTCATCCACGACATGCAGCGGTACTTCCTGCGCCCGTTCGCGGACGAGGTGCGCGTCCCGCTCGTCAGCAACGTCGCCGGCGTCCTCGACCGGTGCCGCGCGCAGGGCGTGCCCGTCGCCTACACCGCCCAGCCCGGCGGGATGACTGAGGCACAACGCGGCCTGCTCAAGGACTTCTGGGGTCCCGGCATGACCGTCGACGCCGCGGACCGCGAGGTCGTCGAGCCCCTCACCCCGGCGCCGGCCGACCGCGTCCACACCAAGTGGCGCTACAGCGCGTTCTTCAACTCCGGACTGCGCGCGGACCTGCGTGCGCTCGGCCGGGACCAGCTCATCCTGTGCGGTGTGTACGCGCACGTCGGCGTGCTGATGACCGCCGTGGACGCCTACACCAACGACATCCAGCCGTTCTTCGTCGCGGACGGCACCGCGGACTTCTCCGGTGACCACCACCGGCTCGCGCTCGACTACGCCGCGGCCCGCTGCGCGGTCGTGTGCACCGCCAAGGAGGTCCTCGCGTGA	MGIPPIPAYPLPGASELPDNVATWQPDPDRAVLLIHDMQRYFLRPFADEVRVPLVSNVAGVLDRCRAQGVPVAYTAQPGGMTEAQRGLLKDFWGPGMTVDAADREVVEPLTPAPADRVHTKWRYSAFFNSGLRADLRALGRDQLILCGVYAHVGVLMTAVDAYTNDIQPFFVADGTADFSGDHHRLALDYAAARCAVVCTAKEVLA	MSKLFVFFMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNTDAYLIDTPFTAKDTENLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKYSFSGVSYWLVKKKIEVFYPGSGHAPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPKSAKLLMSKYSKAKLVVPGHSDIGDSSLLKLTWEQTVKGFNESKKSTTAH	84.08	gnl|BL_ORD_ID|3614|hsp_num:0	4683			456	504	
BGC0000274.1|Tetarimycin_17 # 15231 # 15437 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.667	BGC0000274.1|Tetarimycin_17 	15231	15437	-	Loose	100	38.1206	vanU gene in vanG cluster	36.21	3004253	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanU	ATGCCGATCGTCGTGCGCATCGACGTCGAGCTGGCCAAACGGAAGATGAGTGTGGGGGAGTTCGCCGAGAAGGTGGGGATCACGCCGGCGAACGTGGCGGTGCTGAAGAACGGGCGCGCCAAGGCCGTGCGGTTCAGCACCCTGGAGGCCATGTGCCGGGTCCTCGAGTGCCAGCCGGGTGACCTGCTCGAGTGGGTCGAGGAGTGA	MPIVVRIDVELAKRKMSVGEFAEKVGITPANVAVLKNGRAKAVRFSTLEAMCRVLECQPGDLLEWVEE	MRVSYNKLWKLLIDRDMKKGELREAVGVSKSTFAKLGKNENVSLTVLLAICEYLNCDFGDIIEALPETPDKERDS	90.67	gnl|BL_ORD_ID|4736|hsp_num:0	943			33	201	vancomycin
BGC0000274.1|Tetarimycin_18 # 15437 # 15916 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.646	BGC0000274.1|Tetarimycin_18 	15437	15916	-	Loose	500	25.7942	mphK	39.39	3004541	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAAATGGGAGCGTTGGGCGGTGGCCCTGCTGAGGGTGTTCCTCGTGGTGTTGTTCGGGATCCTGGTCGTGTTTCAGGTGCTGTCCATGCCGGGGCAGTTCGCGCACATGGCTCGGGAGTCGCCGGACGAGGCGTACCTGCGGTGGCCGCTGACCGCCATCGCGGTCTTCTGGTTGTTGTGCGTCGAGGTGGTGATCGTGTGCACCTGGCGGTTGCTCACGCTGGTCAAGAACGACCGGATCTTCAGCGAGTCCGCGATGAGGTGGGTGGACGGGATCGTCCTGGCCATCGGTGCCGCGTGGCTCGTGTTGGTGGGCGTCGACATCTTCGTCGCCTTCAACGCTGATGATCCCGGGATGCCGATGCTGCTGCTCCTGGTGACGACCGGGCTCACCGTGCTGGGACTGTTGATGGTGGTGATGCGTGCGCTGCTGCGGCAGGCCACCGCGCTGCGCACCGATATGGAAGCGGTGATCTGA	MKWERWAVALLRVFLVVLFGILVVFQVLSMPGQFAHMARESPDEAYLRWPLTAIAVFWLLCVEVVIVCTWRLLTLVKNDRIFSESAMRWVDGIVLAIGAAWLVLVGVDIFVAFNADDPGMPMLLLLVTTGLTVLGLLMVVMRALLRQATALRTDMEAVI	MTNLNEKQLITEIVGLARSQGLTVHSENAQLNETGMDFQVVFAKDDTGMPWVLRKPRRSDVVERASAEGITLAFLRANLTADVPDWRIHTPELIAYPMLKGTPAAGIDLEQKQYVWNMDHQPPSDDFVRTLADILAELHGTDQISAGQSGIEVIRPEDFRQMTADSMVDVKNKLGVSTTLWERWQKWVDDDAYWPGFSSLIHGDLHPPHILIDQNGRVTGLLDWTEAKVADPAKDFVLYQTIFGEKETARLLEYYDQAGGRIWAKMQEHISEMQAAYPVEIAKLALQTQQEEHINMALEALGVTSD	51.96	gnl|BL_ORD_ID|2624|hsp_num:0	3217			60	159	telithromycin; azithromycin
BGC0000274.1|Tetarimycin_19 # 16135 # 17955 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.714	BGC0000274.1|Tetarimycin_19 	16135	17955	+	Loose	1000	181.415	msbA	26.94	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGTCGAGGCGGGCTGGTGGCAGACCGTCCGCTCGGTGCCGGCGGCGGTCGCGACGGTGGCGCGGCTGTCCTGGCAGGCCTCCCGTGCCCTGACCTCGGTGGCCGCCGTGCTGCACCTGCTGTCGGGCTGCGTCACCGCGTTCGGCCTGCTGGCCACGGCCGACGTGCTGACCACACTCCTCGAGCAGGGGCCGACCCCCGACCGGGTGCTCGCCTCGCTGCCGGCGATCGCCCTGGTGACCGGCGCCTTCGCCCTGGGTGCGGTGCTCGACGCCGCCGTGGCGCTGGTGCAGGGCATGCTGACCCCGCAGGTCGAGCTGGCCGCCAGGGAACGGATGCACGAGGCGGTGCTCGGCGTGGAGGCCGCCTCGTTCGACGACGCCGACTTCCGCGAGCTGGTGCGCCAGGGCGGTGAGCGGGGCACCAGCTCGATCCGGATGTCCACCGAGGGCGTCGCGAACCTGCTGTCGTCGGTCGTGTCGCTGATGGCGGCGATGGCGACGGTCACGGTGTTCAGCGCATGGCTGTTGCCGGCACTGCTGCTCGCCGCCGCGGTGGACGGGTGGTCGGCGATGCGCGCGGCCAAGCTCAACTACGAGTCGTTCCTCCAGATGATCACGCGGGACCGGCAGTCCTACGTGGTCAGCGACCTGATCACCGACCGCGACGCGGCGCTGGAGGTGCGGGCGTTCACCACCCAGCCGGTGCTGCTGTCGGAGTACCAGCGGGTGGCGAAGATCCTCGCCGCCGAGTCGATCAGGGTGGAGCGGCGGCAGACCTGGATCCAACTCGTCGGCAGGACGCTGGCGGGTGTCGGCACGGCACTGGGCTACGTCGTGCTCGGCTGGCTGCTCTACGTCGAGGCGATGCCGCTCGCGCTGGCCGGCGCCGCGGTGATCGCCATGCGCACCGGTTCCACGGCGCTGCGGAACACCATCTACCAGGTGAACCGGTTGTACGAGCAGAGCTTCCACATCGACCTGTACCGGAAGCTGCTGGTCGACGCGGCGGAGCGCCGCGGCCCGGAGCCGGTCGCACACGCCCCGGCCAACCCGGCGACCATCGAGCTGCGGGACGTCACGTACACCTACCCAGGCCAGAACTCCCCCGCCCTGCAAGGGATCTCGCTGAAGATCCGGCGCGGCCAGGTGATCGCGCTCGTCGGCGAGAACGGCTCGGGCAAGTCGACGCTCGGCAAGCTGATCACCGGCCTGTACCGGCCGACGGCGGGACAGGTGCTGTGGGACGGCACCGACCTCGCCACCGCGCACCGGCAGTCCGTGCACGACCAGATCTCGGTCATCACCCAGGAACCCCTGCGCTGGCCGGTGACCGCGGCCGACAACATCCGCATCGGCCGCCTCGACCGAGACGCCCCCGACGGTACACTGTGGACGCTGCACGCCGAGACCTCCGGCGCGGACGAGGTGATCGACGGCCTGCCCCACAAGGAGGACACGATCCTGTCCCGCCTGTACGAGGAGGGCAAGGACCTGTCCGGCGGCCAGTGGCAACGACTCGCGGTGGCCCGCGGCGCCTACCGGGAGGCACCGGTACTGGTGGCCGACGAGCCAACCGCGGCCCTGGACGCCAAGGCAGAGGCCAAGGTCTTCACCGCCCTGCAGACCGCGAGCCGCGACGACCAGGGCGAGCGCACCACCGTGCTGGTCACCCACCGCCTGGCCAACGTCCGGCACGCCGACCGCATCATCGTGCTGGACAAGGGCCGCGTCACCGAGGACGGCACCCACGAGGAACTCATGGCCCGCGACGGCCTGTACGCGGAGCTGTACTCCCTACAGGCATCCGCCTACCAGTGA	MVEAGWWQTVRSVPAAVATVARLSWQASRALTSVAAVLHLLSGCVTAFGLLATADVLTTLLEQGPTPDRVLASLPAIALVTGAFALGAVLDAAVALVQGMLTPQVELAARERMHEAVLGVEAASFDDADFRELVRQGGERGTSSIRMSTEGVANLLSSVVSLMAAMATVTVFSAWLLPALLLAAAVDGWSAMRAAKLNYESFLQMITRDRQSYVVSDLITDRDAALEVRAFTTQPVLLSEYQRVAKILAAESIRVERRQTWIQLVGRTLAGVGTALGYVVLGWLLYVEAMPLALAGAAVIAMRTGSTALRNTIYQVNRLYEQSFHIDLYRKLLVDAAERRGPEPVAHAPANPATIELRDVTYTYPGQNSPALQGISLKIRRGQVIALVGENGSGKSTLGKLITGLYRPTAGQVLWDGTDLATAHRQSVHDQISVITQEPLRWPVTAADNIRIGRLDRDAPDGTLWTLHAETSGADEVIDGLPHKEDTILSRLYEEGKDLSGGQWQRLAVARGAYREAPVLVADEPTAALDAKAEAKVFTALQTASRDDQGERTTVLVTHRLANVRHADRIIVLDKGRVTEDGTHEELMARDGLYAELYSLQASAYQ	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	104.12	gnl|BL_ORD_ID|2185|hsp_num:0	2423			27	1737	metronidazole
BGC0000274.1|Tetarimycin_20 # 17969 # 18181 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.714	BGC0000274.1|Tetarimycin_20 	17969	18181	-	Loose	200	31.9574	YajC	45.95	3005040	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; oxazolidinone antibiotic; glycopeptide antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCGGACCGGCTGAGCCATCGGAACTCCTGGCGTTCCTGGGGTCACTACGCCGCGGCGACGCCGTCACCGTGGGCCAGGAACTGCGTGGCCGGGTCACCAAGGTGGTGGCGATCGGCGTCTTCGTCCACGTCGCCGACGGAGTCGAGGGTCTGGTGCGTCCGCGGGAGCGGCGCAGGCTGACCCTCTCCCGGGCAGGCTCGTTCGCCTGA	MGGPAEPSELLAFLGSLRRGDAVTVGQELRGRVTKVVAIGVFVHVADGVEGLVRPRERRRLTLSRAGSFA	MSFLIPAAYADAAAPAAAGPAGTGFEWVFLVGFLVIFYLMIWRPQAKRAKEHKNLLGNLQKGDEVVTSGGIAGKVTKVADDFVVVEVSDNVELKFQKAAIAATLPKGTLKAI	62.50	gnl|BL_ORD_ID|2771|hsp_num:0	3783			165	276	vancomycin; tigecycline; tetracycline; linezolid; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000274.1|Tetarimycin_21 # 18223 # 19086 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000274.1|Tetarimycin_21 	18223	19086	-	Loose	700	25.0238	Escherichia coli mdfA	50.0	3001328	protein homolog model	n/a	n/a	tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCTCGTTTCGGGATCATGACCGCACCGTCGCAGGTGGACTACCAGGACGTCCTGCGGGTGTGGCGCGAAGCGGACGCGATCCGGGAGATCGAGCACGCGTGGCTGTACGACCACCTGCTGCCGATCTTCGGCGACCTCGACGGGCCGACGTACGAAGGCTGGACCCTGCTGGCGGCCCTGGCCGCGCGGACCAGCCGGTTGCGCCTGGGCCTGCTCGTGACCAGCAACCGGTTCCGCCCGCCGGCACTACTGGCCAAGATCGCCACCACCGTCGACATCGTCTCCGGCGGACGGCTCGACTTCGGCATCGGCGTCGGCTCCCGCCCGAGCCACCCACTGGCGAGACGCGAGTACGACGCACACGGGCTGCCGTTCCACGACACAGCCCACGCCGTGGGCAGCTTCGCGGAGGCGTGCACGGTGATCAAGCGACTGTGGACGGAGAAGGAACCGTTCGACTTCCACGGCGAGTACCACAACCTGACGGGAGCGTTCGGCAACCCCAAACCCGTCCAGCACCCCCACCCACCCATCATGATCGGCGGCCGCTCATCCGCGACACTGCGCGTGGTGGCCGAGCACGCCGACCTGTGGAACATCCCGAGCAGCGGCGACATCGCCGACGTCGCCGCCCGCGGCGCACTGCTGGACCGCTACTGCGCCGAGATCGGCCGGGACCCCGCGTCGATCACCCGCTCGCTCCACCTGCAGGTCACCTACGACGAACCGGCAGCCACCCGCACCGCGATCGCCGAGGCACTCGACGCCGGCTTCGAGCACATCGTCCTCGGCCTGCCGGCGCCCTACCCGGACGGCGTCGCACGGTGGGTCGCCGACGAGTTGATCACCACGGCCACCTAG	MPRFGIMTAPSQVDYQDVLRVWREADAIREIEHAWLYDHLLPIFGDLDGPTYEGWTLLAALAARTSRLRLGLLVTSNRFRPPALLAKIATTVDIVSGGRLDFGIGVGSRPSHPLARREYDAHGLPFHDTAHAVGSFAEACTVIKRLWTEKEPFDFHGEYHNLTGAFGNPKPVQHPHPPIMIGGRSSATLRVVAEHADLWNIPSSGDIADVAARGALLDRYCAEIGRDPASITRSLHLQVTYDEPAATRTAIAEALDAGFEHIVLGLPAPYPDGVARWVADELITTAT	MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMRQPGMLENVEQYQAGIEWVPTSMNAYLAGGMFIQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLHGISLCFIGAVGYDAIQESFEEAVCIKITALMANVALIAPLLGPLVGASWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFLSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASVMSKGTVSAAMGMLQMLIFTVGIEISKHAWLNGGNGLFNLFNLVNGILLLSLMVIFLKDKQMGNSHEG	70.00	gnl|BL_ORD_ID|2419|hsp_num:0	37			879	945	tetracycline; benzalkonium chloride
BGC0000274.1|Tetarimycin_23 # 20209 # 20778 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.688	BGC0000274.1|Tetarimycin_23 	20209	20778	+	Loose	400	40.0466	MexL	33.75	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGTGAAGGACAGCGACGGGCCCAAACCCAAGCGGGCAGACGCCCGACGCAACGAGAAGACCCTGCTCGACGCGGCCGCCGCGATCTTCGTGACGTCCGGCGTCGACGCACCGGTACGTGACATCGCGGCCAGGGCAGGCGTCGGGACGGCCACGATCTACCGCCACTTCCCGACACGGGCGGACCTCATCATCGCCGTCTACCGACACCAGGTGGAGGCCTGCGCCGAGGCCGGCCCCGCACTACTGGAGAACAGCGCGACCCCGTATGCCGCGCTGGGCCAGTGGATCAACCTCTTCGTGGACTTCCTGGTGACCAAGCACGGCCTCGCCGAGGTGCTGCGCTCGGACAACGCCGGTTTCGAGGCGCTGCACACCTACTTCCTCGACCGCCTCGTACCCGTGTGCACACAACTGCTCGACGCCGCGACCACCGCGAACGAGATCCGAACCGACGTGGCGGCCCTCCAACTCATGCGCGGCGTGGGCAACCTCTGCATCGGCGCCGACGACCCCCGCTACGACGCACGCCGGATGGTCGACCTCCTCATCGCCGGCCTACGCCGCTAA	MVKDSDGPKPKRADARRNEKTLLDAAAAIFVTSGVDAPVRDIAARAGVGTATIYRHFPTRADLIIAVYRHQVEACAEAGPALLENSATPYAALGQWINLFVDFLVTKHGLAEVLRSDNAGFEALHTYFLDRLVPVCTQLLDAATTANEIRTDVAALQLMRGVGNLCIGADDPRYDARRMVDLLIAGLRR	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	89.15	gnl|BL_ORD_ID|4690|hsp_num:0	2219			15	240	erythromycin; tetracycline; triclosan
BGC0000274.1|Tetarimycin_24 # 20859 # 21479 # -1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.731	BGC0000274.1|Tetarimycin_24 	20859	21479	-	Loose	900	28.1054	smeC	34.55	3003053	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCGGGTCACGATTGTCGGCGCGAGCGGGCGCACCGGTCGGCTGGTGGTCGACCGTGCGCTCGCCGCCGGCCACGAGGTCACGGCGGTGTCGAGGTCGGGTGCCGTCCCCGGCGACGTGCGGGCCGATGTACTGGACCCCGCCGCACTGCGCACGGCGGTGGCGGACAGCGACGTCGTGGTGTCGACCATCGCACCGCCCCTGCGTGACCTGCTCCGTCCGACGACGCTGTACTCGACCGGCACGGCGAACCTGATCGACGCCATGCGGGAACACGGGGTGGCCCGGCTGGTCGCCGTGTCGTCGGCGGGAGTCCTCGACGGGGACCCGTCACACCCGTGGCTCTACCGGCGCGTGCTGAAACCGCTGCTGTTCGACCGCGGCCTCTACCGGGACATGCGCGTGATGGAACGCGAGGTGGAGAACAGCGGCCTGCGCTGGGTCATCGTCCGTGCCGCCGGCCTCACCAACGGCGCGGCGACCGGCACCTACCGGGTGGAGGACGGGCGCCTTCCCGCCGGCGGGACCCGGATCTCCCGCGCCGACCTCGCGACCTTCCTCGTGACCCAGCTACCAGCCGACGCGGAGTACACCGGCCGGCACCCGACCCTGGCCTACTAG	MRVTIVGASGRTGRLVVDRALAAGHEVTAVSRSGAVPGDVRADVLDPAALRTAVADSDVVVSTIAPPLRDLLRPTTLYSTGTANLIDAMREHGVARLVAVSSAGVLDGDPSHPWLYRRVLKPLLFDRGLYRDMRVMEREVENSGLRWVIVRAAGLTNGAATGTYRVEDGRLPAGGTRISRADLATFLVTQLPADAEYTGRHPTLAY	MKPMLLRALAAATMTTVLGGCVSMAPHYQRPEAPVPAQFGNAAIGAAEPALAMPAWRDVFLEPRLQQVIALALQNNRDLRVAVLQVEKERAQYRIQRAALLPSVDASGSVTRSRVSDANSETGVTQVTESDAVQVGISSWELDLFGRIRSLKNEALQNWLASAENQRAVRTSLVAEVATAWLALAADEQSLAFTQQTLDSQHQTLQRTEARHAQGLASGLDLSQVQTSVEAARGALAKLQAQQAQDRDALQLLVGAPLDPALLPTAQALDGSVALAPLPANLPSSVLLQRPDVLSAEHALQAANADIGAARAAFFPTLALTANYGHSSTALSTLFSAGTRGWSFAPSITAPIFHAGALKASLDASKIGKDIGIAQYEKAIQQAFSEVADALATRDHLTAQLDAQRALVADSQRSYTLADARYRTGLDGYLQSLDAQRSLYAAQQDLIALQQQEAGNRVTLFKVLGGGADAR	43.74	gnl|BL_ORD_ID|1160|hsp_num:0	1264			228	393	
BGC0000274.1|Tetarimycin_25 # 21503 # 23080 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000274.1|Tetarimycin_25 	21503	23080	-	Loose	900	109.383	iri	27.96	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGTCCGGTGTGGAGAGTACGCGGGTACTCGTCGTCGGTGGGGGAGTCAGCGGGCTGTCGGCCGCGGCGTTCCTCGCCGGCCAGGGGGTCGGGTGCCTGCTCGTGGAACGGCGTGCCGGCCACTCGGCGCACCCCAGGATGAGCGACCTCGGGCCGCGGTCGATGGAGCTGCTGCGCGGCGTCGGGCTGGAGGACCGGATCCGCGCGCTGGACGAGGGCCGCGAGAGCCTGATCCTGCGGGTGGACACCCTCGCGGGCACCGAGCTCGAACGGCACTCGATGGGTGGCCACGAGGAGTTCGGCGGGCTCACCCCGACCCCGCAGGTCTGGTGCGACCAGGACCAGTTCGAGCCGATCCTGCGAGCACGGGCCGAGGAGCTGGGCGCCGACGTGCGCTTCGGCGTCGAGCTGGTCGAGCTGACCCAGGACGCCGACCAGGTGCGTGCCGTGGTCCGCGACCGGGGGACCGGTGAGGAGCGAGTGGTCGTCGCGTCCTATGTGCTCGCCTGCGACGGCGCGCAGAGCCCGCTGCGTGAGCGGGCCGGGATCACGCTGTCCGGACCGGGCGTCCTGGCGCACCAGGCCGGCATCCTGTTCCGCGCCGACCTGGGCCCCGCGCTGCGTGGCAGGACGTTCGTGCTGTGCCTGGTCGCCCCGCTCGTCGAGAGCAGCGACCACCTCAACATCCTGCTGTCGCGCAACCTCAACCGCTGGACCCTCAGCGTGCCGTACGACCCGGAGCGCGGCGAGGACCTGGACCCGCGCCGCTGCACCGAGCTCGTCCGCGCGGCGACCGGGCTGCCCGACGTGGCGGTCGAGGTGCTCGGCGTCGACCGCTGGCCCATGCGCGGGCTGGTGAGCGACCGGTTCCGGGACGGGCGGGTGTTCCTCGTCGGCGACGCCGCGCACGTGCTGCCGCCGACCGGCGGGTTCGGCGGGAACTCGTGCGTCGAGGACGCGCACAACATCGCGTGGAAGCTGGCGGCCGTGCTGGACGGGACAGCCGGCCCCGCGCTGCTGGACACGTACGAGGCCGAACGGCTGCCGAGGGCCCGGCTGCTGCTCGGCGAGTCGCTGGCCCGTGCCGGCCTGTTCCTCGCCGGCGCGGCGGAGGGCGGCTCACGCCAGCCGCAGAACCACCCGAGCAAGGCGAGCCTCGTGCTCGGCTACCGCTACGGCGACGGCCCGCTGGTCGAGGACCCGTGGCAGCCACCGAGCGGCCCGGGCGGCCGCGCACCACACCTCACCGTGTCGGTGGCCGGCACGGAGATCTCCACGCTGGACCTCTTCGGCCGTGGTTTCGTACTGCTGACCGGCGCACGGGACTGGCACACGGCGGCGAGCGAGGTCACCGGTGTCACGCCGTACCTCGTGGGCCCGGACGCTGAGGTCGTGGCCCCGTCCGGCCGCTGGGAGAGCGTGTACGGCGTGCCACCGGGCGGCGCGGTACTGGTCCGCCCGGACGGCCACATCGCCTGGTACGGCGGTCCCGGTCCGGACCGACCGGCACAGGCGGTGCGCGACGCCCTCGCGGCGGCCCTGCACACCCAGCGGGCGGCGGTAGTTCCCGTTCGCTGA	MSGVESTRVLVVGGGVSGLSAAAFLAGQGVGCLLVERRAGHSAHPRMSDLGPRSMELLRGVGLEDRIRALDEGRESLILRVDTLAGTELERHSMGGHEEFGGLTPTPQVWCDQDQFEPILRARAEELGADVRFGVELVELTQDADQVRAVVRDRGTGEERVVVASYVLACDGAQSPLRERAGITLSGPGVLAHQAGILFRADLGPALRGRTFVLCLVAPLVESSDHLNILLSRNLNRWTLSVPYDPERGEDLDPRRCTELVRAATGLPDVAVEVLGVDRWPMRGLVSDRFRDGRVFLVGDAAHVLPPTGGFGGNSCVEDAHNIAWKLAAVLDGTAGPALLDTYEAERLPRARLLLGESLARAGLFLAGAAEGGSRQPQNHPSKASLVLGYRYGDGPLVEDPWQPPSGPGGRAPHLTVSVAGTEISTLDLFGRGFVLLTGARDWHTAASEVTGVTPYLVGPDAEVVAPSGRWESVYGVPPGGAVLVRPDGHIAWYGGPGPDRPAQAVRDALAAALHTQRAAVVPVR	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	109.60	gnl|BL_ORD_ID|729|hsp_num:0	796			9	1371	rifampin; rifaximin; rifabutin; rifapentine
BGC0000274.1|Tetarimycin_26 # 23088 # 23522 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.632	BGC0000274.1|Tetarimycin_26 	23088	23522	-	Loose	556	23.483	erm(32)	39.29	3004592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCCCGTCGTCACCCGTTCGGTCATGGTGGACGCCCCGGTCGGCGTCACGTTCGACGTCTCCAACCGGATCGACCAGTGGCCGAGGATCGTGCCGGAGTACCTGGAGACCGAGATCCTGCGCCGGGAGGGCCGCAAGATCTGGTTCCGGCTGACCAACCAGGACAATCTCTCGTGGATCTCGTGGCGGATGCTCTACCCGCCCTACCTGGCCTACGCCGAGCGGTCCGAACCGGTCGCGCCGTTCGTGTTCAACCAGCTCACCTGGGTTTACCATGCGATGCCAGGCAACAGAACACACATGACGTGGGACATGTACTTCGAGTTGCCTGCGGAACGCAAGCACGAGGAGAACGCGTGGGCGGAACGGATGGCGGAGCACACGGAGGCCAACCAGAAGGCCATGCGCAGCTACATCGAGTCGCGGAGTTGGTGA	MPVVTRSVMVDAPVGVTFDVSNRIDQWPRIVPEYLETEILRREGRKIWFRLTNQDNLSWISWRMLYPPYLAYAERSEPVAPFVFNQLTWVYHAMPGNRTHMTWDMYFELPAERKHEENAWAERMAEHTEANQKAMRSYIESRSW	MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP	51.43	gnl|BL_ORD_ID|2699|hsp_num:0	3294			603	687	narbomycin; methymycin; pikromycin
BGC0000274.1|Tetarimycin_28 # 24437 # 26308 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.707	BGC0000274.1|Tetarimycin_28 	24437	26308	+	Loose	400	31.5722	vanR gene in vanF cluster	28.95	3002925	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGACAAACGACAAAGAGTGTCAACGACCATCCGACGAAGTGGTTGAACTTGGGGACACACGTATGCGTTTTTCCGTACTGGGCGACTTCGCGGTCGCCACGGCAGGCCAGGACATCACCCCGACGCCAGCGAAACTACGCACCATCCTCGCCCTGCTCGCCATCCGCGCGGGCGAGAGCGTGAGCCGGAATTCGATAATCCAGGAAATCTGGGGCGAGGCACCTCCGGAAAGCGCGTCCGGTGCGGTCCACACCTACATCTACGAACTGCGGCGAGCATTCAGGTCGAGCGGTTGCGGTTCGGACGTCATCGTCACCAAACCGAACGGTTACACGCTGAGCAGCTCGAACGCGGACCTCGACTTCCGCCGGTTCGACGAGCTGCTGCGCGAAGGCACGACAACGGCGCGGGACGAACGCCGCGCCGGGTCACGGGACGCGCTGGAGGAGGCGAGCGACCACCTCACCGAGGCGCTGGCGCTGTGGCGCGGCGAGCCGCTGGCGAACGTGACCTGCGGCGAACAGCTGGCCACCCACGCCGTCTGGCTGGAGGAGCGGCGCCGGCAGGCACTCGAGCTGCGGCTGGAGGTGGACATGCGGCTGGGCCGGGGACCTGACCTGGTCGGCGAGCTGAAGGTGCTGACCGAGCGGTACCCGTACCACGAACGGTTCCACGAGATCCTCATGCGTGCGCTCGCCGGGGCGGGCCGGCGGTCGGAGTCGCTGGACGTCTACCGGCTGCTCCGCACCAGGATGGCCGAGGAGTTCGGGCTCGAGCCGAGCCCCAGGTTGCAGCGGCTGCAGCACGCGCTGCTCGTCGGCGACCAGCGGTTCGAACCGGAGCAGCCGGTCACCCGGCCGAGGATGCACCCGACCCAGCTGCCGCCGGACGTGCCGGACCTGTGCGGACGGCAGGACGTGGTCGACCAGATGTGCCGGTACCTCACCGCCCCGCACGGCACGACCGGCCCGGTCGTGTGCCTGCACGGGATGGCGGGCGTCGGCAAGAGCACGGTCGCGGTCGGGGTCGCGAACCGGCTGGCGCCGCATTTCCCCGGTGGCCAGATCTACCTCGACCTGCACGACACCCACGCCGGCTCCACCACGGCGAGCACCGTGCTCGGCGGGTTGCTGCGTGCGCTCGGTGTCGCCGAGGCCGACCTACCGTCCACAGTGGAGGAATGTGTCGGTGCGTTCCGGTCGCTGACGCTGGACGGCCGGGTGCTGCTGGTGCTCGACGGGGTGAAGCCGCACATCCCGGTGGCCCGGCTGCTCCCCGCGGCCTGCGCCACGATCATCACCAGCCGGTGGCCGATGCACGGCATCGCGGGCGCGCGGAAGATCACCCTCGACGCCTTCGACACCGAGGAGGCCATGACCCTGCTCGCCAGGATCGCCGGCTCGGAACGGATCCGCGCGGAACGGGACGTCGCCGAGGGCCTTGTCGACCGGTTCGGCGGCCTGCCCCTCGGGGTCCGCTTCCTCGGTGAGCGGTTGTCGTCGGCACCGGAGACGACGCTGACGCAGCTGTGGTCGCTCATGGTCGCCGCCGGCCACGACGCGTGGCTCGCCGACCTCGGCCGCATCGGGTTCGACCTGTCCGACCGGCTCGACGCGACCTACCGCGAGCTCAACGCCGCGGAGCGCGCCGCGGTCGGCGTGCTCGGCCCGTTCCGGCACGGGAAGTTCACCACCCGCGACGTCGCCGAGGCGATGGCCGGCCCGGTCACCCAGGCCGAGCTGGTCCTCACGAGCCTCGTCGACGCGAGCCTCGTCCACGCCGTCGGTCACGACGAGCGGGGCGACCCGGTGTACGCCCTGCCGCGGTTGGTGGGGCGCTATGCCATGGAACGCGCGGAGCGCGGTGACTGA	MTNDKECQRPSDEVVELGDTRMRFSVLGDFAVATAGQDITPTPAKLRTILALLAIRAGESVSRNSIIQEIWGEAPPESASGAVHTYIYELRRAFRSSGCGSDVIVTKPNGYTLSSSNADLDFRRFDELLREGTTTARDERRAGSRDALEEASDHLTEALALWRGEPLANVTCGEQLATHAVWLEERRRQALELRLEVDMRLGRGPDLVGELKVLTERYPYHERFHEILMRALAGAGRRSESLDVYRLLRTRMAEEFGLEPSPRLQRLQHALLVGDQRFEPEQPVTRPRMHPTQLPPDVPDLCGRQDVVDQMCRYLTAPHGTTGPVVCLHGMAGVGKSTVAVGVANRLAPHFPGGQIYLDLHDTHAGSTTASTVLGGLLRALGVAEADLPSTVEECVGAFRSLTLDGRVLLVLDGVKPHIPVARLLPAACATIITSRWPMHGIAGARKITLDAFDTEEAMTLLARIAGSERIRAERDVAEGLVDRFGGLPLGVRFLGERLSSAPETTLTQLWSLMVAAGHDAWLADLGRIGFDLSDRLDATYRELNAAERAAVGVLGPFRHGKFTTRDVAEAMAGPVTQAELVLTSLVDASLVHAVGHDERGDPVYALPRLVGRYAMERAERGD	MKNITILIADDDAEIADLVAIHLEKEGYRVIKVSDGQETIDVIQNQPIDLLILDIMMPKMDGFEVTRRIREKHNMPIIFLSAKTSDFDKVQGLVIGADDYMTKPFIPIELVARVNAQLRRFMKLNQPKTKQNSNLEFGGLTISPEQRTVTLYGKNIELTPKEFEILFLLASNPNKVYRAEDIFQKVWGDAYYEGGNTVMVHIRTLRKKLEEDKRKNKLIQTVWGVGYKFNG	269.70	gnl|BL_ORD_ID|298|hsp_num:0	240			441	663	vancomycin
BGC0000274.1|Tetarimycin_29 # 26357 # 26794 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0000274.1|Tetarimycin_29 	26357	26794	-	Loose	500	25.0238	BJP-1	57.89	3000856	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BJP beta-lactamase	ATGACCGGTCGCAGCCGGGCCTCGGAGCTGTTGGAGCAGGTGCGTTCCCAGGCGGTCGCGTTCCTCACGGCCGTACCCCAACCGCCGAGGGCACTGCGGATCCGCGCGCACGCGGTGGAGCTCGACGCGGAATGGGCCGACGTGACGCGGACCGGCACCGCCGGGGAGGACGTGCCTGCCGTACCCGGGCACACCGCGATCACCGCGGCCACCGTCGGTGTCTTCTACGCGGCACCGCAACCCGGCGCACCGCCGTTCGTGCGCCCCGGTGAGGTGGTCACCGCTGGTCAGCAGGTCGCCATCATCGAGACCATGAAGCTGATGATCCCGGTCGAGGCGACCCGGCCGGGCCGGATCGTCAAGGTGCTCAAGGAGAACGGCGAGTCCGTGGCGTACGGCGACGCGCTGTTCGCCGTCGCGCCGGACGACGTGGGGTGA	MTGRSRASELLEQVRSQAVAFLTAVPQPPRALRIRAHAVELDAEWADVTRTGTAGEDVPAVPGHTAITAATVGVFYAAPQPGAPPFVRPGEVVTAGQQVAIIETMKLMIPVEATRPGRIVKVLKENGESVAYGDALFAVAPDDVG	MRRLTAALCALTLLSTGAQAQTIKDFLAVAMKKWTAPFEPFQLIDNIYYVGTDGIAVYVIKTSQGLILMDTAMPQSTGMIKDNIAKLGFKVADIKLILNTHAHLDHTGGFAEIKKETGAQLVAGERDKPLLEGGYYPGDEKNEDLAFPAVKVDRAVKEGDRVTLGDTTLTAHATPGHSPGCTSWEMTVKDGKEDREVLFFCSGTVALNRLVGQPTYAGIVDDYRATFAKAKAMKIDVLLGPHPEVYGMQAKRAEMKDGAPNPFIKPGELVTYATSLSEDFDKQLAKQTAALEKK	49.32	gnl|BL_ORD_ID|1936|hsp_num:0	1942			756	813	
BGC0000274.1|Tetarimycin_30 # 26791 # 27024 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.701	BGC0000274.1|Tetarimycin_30 	26791	27024	-	Loose	600	26.9498	vanJ	40.54	3002914	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanJ membrane protein	ATGAGTACCGATGAGCTGCTCGAGGTCCTGCGCACGTGTGCGGGGGAGAGCGAGGACGGCGCACTCGACGAGTCCGCGCTCGACCGGGACTTCGCCTCGCTCGGCTACGACTCGCTGGCACTGCTGGAGATCACCGGGCACCTGCGGCGTGCGTACCGGGTGTCCATCGCCGAGGACGCGGTCGGGCTGGGGGACAGCCCGCGCCGGCTCCTCACGCTGGTGAACGAGACATGA	MSTDELLEVLRTCAGESEDGALDESALDRDFASLGYDSLALLEITGHLRRAYRVSIAEDAVGLGDSPRRLLTLVNET	MVLRSAARPELWKRAPVLTVSALLLGLVMMLHAEIPNRFGSVGSLVETFLPWFGLFVPVLAAGALWRRSAAAVTALVLPVTVWLSLFGGLLGDKSGAGGEFTMASHNVGAENPDPAGTARDLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDYGPLADTKPADVTMAGNRALRTTVATERGPLVVYVAHLGSVRLNPRAGFWTDSRDRNAWALGEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQILVRGVEPTGSWTLPATGSDHLPVAAGVSW	23.33	gnl|BL_ORD_ID|2036|hsp_num:0	2240			339	450	teicoplanin
BGC0000274.1|Tetarimycin_31 # 27021 # 28247 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.760	BGC0000274.1|Tetarimycin_31 	27021	28247	-	Loose	500	26.1794	APH(3'')-Ia	38.78	3002638	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	ATGCGCGTCATCGTCACCGGCCTCGGCATCGCGGCGCCGACCGGGCTCGGCGTGGCCGACTACTGGGCCGCGACACTGGCCGGGGAGAGCGGGATCGGGCCCGTGCGCCGGTTCGACGCGAGCGGGTACCCGTGCTCGCTGGCCGGCGAGGTGCCCGGGTTCGCCCCGGCCGACCACCTGCCGAGCCGGCTGCTCCCGCAGACCGACCACATGACGCGGCTCGCGCTCGTCGCGGCGGACGAGGCGATCGCCGACGCGCGCGTGGTCCCGGCGGAGCTGCCCGAGTACGGGATGGGTGTGGTCACCGCCAGCTCGTCGGGTGGCTTCGAGTTCGGTCAGCGGGAGCTGGCGAACCTGTGGCGCAGGGGCGGCGAGTACGTCAGCGCCTACCAGTCGTTCGCCTGGTTCTACGCGGTGAACAGCGGGCAGGTCTCGATCCGGCACCGCCTGCGGGGACCGGGTGGCGTGCTCGTGAGCGACCAGGCCGGTGGGCTGGACGCCGTGGCGCACGCGCGCCGGCACGTCCGGCGTGGCACCGACGTGGTGGTCACCGGCGGCGTGGACGGCTCGATCTGCCCGTGGGGCTGGGTCGCGCAGCTCGCCGGCGGCAGGCTCAGCACGGCCACCGCGCCGGACCGGGCCTACCTGCCCTTCGACGCGTCGGCGTCGGGGCACGTGCCCGGCGAGGGCGGCGCGCTCCTGGTGCTCGAGGACGCGGCCGCGCTCGCCCGCCGGCGCGGGCCGGCGGGGTACGGCGAGATCGCCGGCTACGCCGCGACCTTCGACCCGCCACCGGGCAGCGGTGGTGAGCCGGGCCTGCGTGCGGCCATCGAGCTGGCGCTGGCCGACGCCGGTGTCGAGCCGGCCGGCGTCGACGCCGTGTTCGCCGACGCGGCCGCCGTGCCGGAGCTCGACCGCGCCGAGGCCGACGCCCTCGCCGCGGTCTTCGGCCCGCGCGGCGTGGCCGTGACGGCACCGAAGACGATGACGGGCCGGCTGTACTCCGGTGGCGCGCCGCTGGACCTGGCCGCCGCCCTGCTGTCCATCCGGGACGGTCTGCTGCCGCCGACCGTCCACAGTGAACCACGCGACGAGTACCGGCTCGACCTCGTCACGGGCTCGCCGCGGGAGGCCGGGGTCCGGGTCGTGCTCGTGCTCGCCAGGGGACACGGCGGGTTCAACTCCGCGATGGTCGTCCGTGCGACATCAGAGAAGGAGCGACGATGA	MRVIVTGLGIAAPTGLGVADYWAATLAGESGIGPVRRFDASGYPCSLAGEVPGFAPADHLPSRLLPQTDHMTRLALVAADEAIADARVVPAELPEYGMGVVTASSSGGFEFGQRELANLWRRGGEYVSAYQSFAWFYAVNSGQVSIRHRLRGPGGVLVSDQAGGLDAVAHARRHVRRGTDVVVTGGVDGSICPWGWVAQLAGGRLSTATAPDRAYLPFDASASGHVPGEGGALLVLEDAAALARRRGPAGYGEIAGYAATFDPPPGSGGEPGLRAAIELALADAGVEPAGVDAVFADAAAVPELDRAEADALAAVFGPRGVAVTAPKTMTGRLYSGGAPLDLAAALLSIRDGLLPPTVHSEPRDEYRLDLVTGSPREAGVRVVLVLARGHGGFNSAMVVRATSEKERR	MSDHPGPGAVTPELFGVGGDWLAVTAGESGASVFRAADATRYAKCVPAADAAGLEAERDRIAWLSGQGVPGPRVLDWYAGDAGACLVTRAVPGVPADRVGADDLRTAWGAVADAVRRLHEVPVASCPFRRGLDSVVDAARDVVARGAVHPEFLPVEQRLVPPAELLARLTGELARRRDQEAADTVVCHGDLCLPNIVLHPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERARFADAAFAERYGIAPDPERLRFYLHLDPLTWG	150.00	gnl|BL_ORD_ID|1773|hsp_num:0	1923			15	162	streptomycin
BGC0000274.1|Tetarimycin_32 # 28247 # 29389 # -1 # ID=1_32;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.731	BGC0000274.1|Tetarimycin_32 	28247	29389	-	Loose	750	179.489	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	32.04	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	TTGTTCGACCCGGCCGCCTTCCGGTCGCAGGTGGCCGCCGAGGTCGACTTCGACCCGGCGGCGCACGGGCTGACCGCGCAACAGGTGCGCAGGATGGACCGCGCCGCGCAGTTCGCGGTCGTCGCGGCTCGTGAGGCGGTGCGGGACAGTGGCCGGGACCTCGACGTGCTGCCGCCGCACCGCACCGGTGTGGCGATCGGCAGTGCCGTCGGCGCGACCACGAGCCTGGAGCGGGAGTACCGGGTCGTCAGCGACGACGGCCGGCTGTGGCTGGTCGACCACGAGTACGCGGTGCCGCACCTGTACGAGTACCTGGTGCCGAGCTCGTTCGCCGCTGAGGTGGCGTGGGCGGTCGGCGCGCAGGGGCCGGCCACCGTGATCTCCACGGGCTGCACCTCGGGGCTCGACTCGGTCGGCTACGCGTGCGAGCTGATCCGGGAAGGCGCCGTCGACGTGATGGTCGCCGGCGCGACCGACGCCCCGATCTCGCCGATCACCACCGCGTGCTTCGACGCGATCCAGGCGACCACACCGCGCAACGACGACCCGGAGCACGCGTCACGGCCGTTCGACAACACCCGCAACGGGTTCGTGCTCGGCGAGGGCGCCGCGGTGTTCGTGCTGGAGGACCTGGCGAGCGCGCGGCGGCGTGGTGCGCACGTGTACGCGGAGATCGCCGGGTTCGCCTCGCGCTGCAACGCCTTCCACATGACCGGGTTGCGGCCGGACGGCAGGGAGCTGGCCGAGGCGGTCCGGGTCGCGCTGGCGCAGGCCCGCCGCGACCCGACCGACGTCGACTACGTCAACGCGCACGGCTCCGGCACCCGGCAGAACGACCGGCACGAGACGGCCGCGTTCAAGCGGAGCCTCGGCGACCACGCCTACCGGACCCCGGTCAGCTCGATCAAGTCGATGGTGGGGCACTCGCTGGGGGCGATCGGGTCGCTCGAGATCCTGGCGTCCGCGCTCGCCATCGAGCACGGCGTGGTGCCGCCCACCGCCAACCTGCACGAGCCGGACCCCGAGTGCGACCTGGACTACGTGCCGGTCACCGCGCGGGAGTGGCGGACCGACACCGTGCTGACCGTCGGCAGCGGCTTCGGCGGCTTCCAGTCGGCGATGGTCCTGACCAGGTGCTCGTGA	MFDPAAFRSQVAAEVDFDPAAHGLTAQQVRRMDRAAQFAVVAAREAVRDSGRDLDVLPPHRTGVAIGSAVGATTSLEREYRVVSDDGRLWLVDHEYAVPHLYEYLVPSSFAAEVAWAVGAQGPATVISTGCTSGLDSVGYACELIREGAVDVMVAGATDAPISPITTACFDAIQATTPRNDDPEHASRPFDNTRNGFVLGEGAAVFVLEDLASARRRGAHVYAEIAGFASRCNAFHMTGLRPDGRELAEAVRVALAQARRDPTDVDYVNAHGSGTRQNDRHETAAFKRSLGDHAYRTPVSSIKSMVGHSLGAIGSLEILASALAIEHGVVPPTANLHEPDPECDLDYVPVTAREWRTDTVLTVGSGFGGFQSAMVLTRCS	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	91.35	gnl|BL_ORD_ID|1968|hsp_num:0	1943			195	1245	isoniazid
BGC0000274.1|Tetarimycin_33 # 29516 # 30274 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.715	BGC0000274.1|Tetarimycin_33 	29516	30274	-	Loose	1500	25.409	rphB	26.79	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGTCAGTGCGTCTTGACGACCAGGTGGCGATCGTGACCGGGGCGGCGTCGGGCATCGGCGCCGCGGCCGCGGTCGAGCTCGCCTCGGCCGGTGCGACGGTGGTCCTCGCCGACGTGGCGGACTGCGCCGAGACGGCCACGGCGATCGACGAGGCTGGCGGCGAGTGCGTCGCCGTGCCGACCGACGTCTCGAAGGCCGGCGAGGTCGAGGCACTCGTCACCCGGACCCTGGACACCTACGGCCGGCTCGACTGCGCGTTCAACAACGCCGGCATCGAGGGCAGGGCCGAGCTCGAGATCCACGACGCGGATGAGCAGGCGTGGGACCGGGCGCTCGAGGTGAACCTCAAGGGCGTGTGGCTGAGCATGAAGTACGAGGTGCCGGCCATGCTGAGGCACGGCGGCGGCACGATCGTCAACGGCGCCTCGGTGGCCGCGATGGTCGCCTTCGACAAGAACGGCTCCTACGTCGCGAGCAAGCACGCGATCATGGGCCTCACCAAGACCGCGGCCCTGGAGTACGCCGACCGGGGGATCCGCGTCAACGCGGTGTGTCCCGGCGTGGTCCGCACCCCGTTCATCGACCGCTTCACCGGCCGCGACCCGCGGGCGGAGTCCCGCTACACCGCCATCATCCCGCTGGGCCGCATGGCCGAGCCGGCCGAGGTGGCGAAGGCGGTCGTGTGGTTGCTGTCGTCGGAGTCCTCGTACGTCACCGGGCACGGCCTCGTACTCGACGGCGGGCTGGTGGCCCGTTGA	MSVRLDDQVAIVTGAASGIGAAAAVELASAGATVVLADVADCAETATAIDEAGGECVAVPTDVSKAGEVEALVTRTLDTYGRLDCAFNNAGIEGRAELEIHDADEQAWDRALEVNLKGVWLSMKYEVPAMLRHGGGTIVNGASVAAMVAFDKNGSYVASKHAIMGLTKTAALEYADRGIRVNAVCPGVVRTPFIDRFTGRDPRAESRYTAIIPLGRMAEPAEVAKAVVWLLSSESSYVTGHGLVLDGGLVAR	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	28.51	gnl|BL_ORD_ID|2235|hsp_num:0	2528			2373	2541	rifampin; rifaximin; rifabutin; rifapentine
BGC0000274.1|Tetarimycin_34 # 30258 # 31313 # -1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.711	BGC0000274.1|Tetarimycin_34 	30258	31313	-	Loose	500	35.039	chrB	28.37	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGACGGCACAGGAAATCCAGCACAACATCGCGCAGGTCAAGGAACTGGCATGGGGCCTCGTCTCGACGGCCGCCCTGTGCGTGGCGGTGGACCTCGAGCTGGCGGACCACCTCGACGACGGGCCACGTAGCCGGGACGAGCTCGCCAGTGCCACCGGCGCCGACCCGGTGGCACTCGGCCAGCTCCTCGACGCGTTGGCCGCCAGGGGGGTGCTGCACCGCACCGCGGCCGGCGGCTACGCCAACACCGGGCTTTCCCTGCTGCTGCGGAAGAACGACCCCAACAGCATGACCGACCTCGTCCGGTGGATCGGGCACCCGGTGTTCTGGCGCCTGTGGCCGCACCTCGACGACGCGGTGCGGGAGGGCAAGCCGCGGTCGGTCGAGGTGTTCGGCAAGGACTTCTTCCGCTACCTCCACGAGGAGGAACCCGAGGCAGTGGCGACGTTCACCGGCGCCATGACACAGGCCAGCAACCACACGGCGACCGCGATCGCGGACTCCCTCGACCTGTCCGGGACCAGCATGGTCGCCGACATCGGCGGTGGCCAGGGCCGGTTGCTGGCGGCCATCCTGGAGAAGGCCCCGGACGTGCGTGGCGTGCTCCTCGACCTCCCCGGTGTCGTCGCACAGGCACTGCCCGGGCTGCGGGAGGGAACACTCGCCGACCGGGTCACGCTCGTCGGCGGCGACTGCCGGCAGGCCGTGCCCGTCACGGCGGATCTCTACGTGCTCAAGAACATCCTCGACTGGGACGACGCGAGCACCGTGCGGACGCTGGAGAACGTCCGGCGTGCCGCGCCGCCGGGTGCGCGCGTCGTGGTCGTGGAGACGCTGTCCGACCACACGCCGGAACCCGAGGTGACCACGTCGCTGGACCTGCTCCTGCTGCTGAACGTCGGCGGGCACCAGCACACGGCGCGGCAGGTCGCGGACCTGTTCGCCCGCGGCGGGATCCGCTTCGACGGCGTGCGTCCCACCGGCACGTTCCTGCAGCTGGTCGAGGGCACCGTGGCCGCGGGAGAGGAAGGGGCGAACGATGTCAGTGCGTCTTGA	MTAQEIQHNIAQVKELAWGLVSTAALCVAVDLELADHLDDGPRSRDELASATGADPVALGQLLDALAARGVLHRTAAGGYANTGLSLLLRKNDPNSMTDLVRWIGHPVFWRLWPHLDDAVREGKPRSVEVFGKDFFRYLHEEEPEAVATFTGAMTQASNHTATAIADSLDLSGTSMVADIGGGQGRLLAAILEKAPDVRGVLLDLPGVVAQALPGLREGTLADRVTLVGGDCRQAVPVTADLYVLKNILDWDDASTVRTLENVRRAAPPGARVVVVETLSDHTPEPEVTTSLDLLLLLNVGGHQHTARQVADLFARGGIRFDGVRPTGTFLQLVEGTVAAGEEGANDVSAS	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	125.36	gnl|BL_ORD_ID|274|hsp_num:0	305			276	654	tylosin; chalcomycin; mycinamicin
BGC0000274.1|Tetarimycin_35 # 31360 # 34410 # -1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000274.1|Tetarimycin_35 	31360	34410	-	Loose	400	33.4982	vanR gene in vanB cluster	35.56	3002921	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGCTGGACCGGCCGAGGCTGTCCGCGCTGCTGTCCGGTGGTGATGGCACCCGCGGCACCCGGCTGACCACGCTCGTCGCACCCGCCGGCTACGGCAAGACGACGCTGCTGACCGGGTGGGCGGGCCGCACGCGAACCGCCTGGCACACCTGCACGGCGGAGGACCGGGAGCTGCGGCCGGCACTGGACCACCTGGCCGACGCCGTGCGCACCGCGTTGCCGGGCCTGGACTTCACGTTGCCGCCGATGGCCGGCGACGCGCACGCGATGAGCGCGGCGCTGTGCGACGCGCTCGGGTCGGCGGAGCTGGTGCTGGTGCTCGACGACGTGCACGTGATGACCGAGCGGGACGACTCGGTGCGGTTGCTGGAAGGGCTGTGCCGGCAGCTGCCCCCGACCGCACGGCTCGTCCTGTCCGGGCGGCGGCCACCACCGTTCGCGGTGCGGCGGCTGCGGGACGGCGGCCAGCTGGTCGAGCTGACCGCGGGCGACCTCGCGTTCACCGCCGACGAGGTGGCCGCGCTGCTGACCGACCGGCTCGGCCTGTGCGGCGCGGACTTCGCGTGGCTGCACCGGGTCACCGGCGGCTGGCCGATCGCCGTCCGGCTGGCGGGGGAGGCGTTGCGGCACGGGCACGTCACGGACCCGGTCCGGGCCGGGCAGTTCTTCGACTACGTGGCGACGGAGATCGTCGACCGGGAGCCACGGCGGACCCGGGAGCTGGTCCGGGTCGCCGCCCGGTTCCCCCGGTTCCGCCCGGAGCTGCTGGTGGCGCTCGGCCACCCGTACGCAGGGGAGACCATCGCCGACCTCGTCAGCCGGGGCCTGTTCGTGGAGGCGCTGCCGGCCTCGCCCGGCTGGTTCGGGGTCCTGCCCCTGGTCCGTGACTTCGTGCGGACCCGGATGCCCGTGCAGGACTGGGAGCTGCGTGAGCTGTACGACGCGGCGGCCCGCTGGTTCAGCGCCAACGGCCACCTGGACGCCGCGCTGACCGCGCTCGCGGAGCTCGACGACATCGACCGGATCCAGGGCCTGCTCGACGAACGCGCGGACGACCTGCTGCGCGAGGGCGGCGCGGACGCTGTGCTGGCCGCGGTCCGCCTGGTGCCGCCGGAAGCACGGCACCGCAGGACCTGGCAGCTGGCCGGTGAGGCGCACCAGGTGCGTGGCGACTGGTCCAGCGCACTCGACTGCCTCAACCACACCGTCGACAACGGACACACGAGTCCCGACGTGGTGCGGCGGATCGCCTGGTCCCACTACCTCAGCGGGGCGACCGCCGAGGCACTGGAGGTCTGCGGCCGGTGCGAGCCGAACGGCGCCGACCCGGTGGCCGAGTCGTTGCTCGCCAGCTGTGCCGCCGGCGCCCGGTGGGCACGCGGTGAGCTGGCCGAGTGCCGGACCGCGGCCCGCCGGGCCATGACGCTCGCGAGGGGGAGCGGTGACGACGCCGCGCTCGCGGCCGCGCACACCGTGCACGCCATGCTCGCCGCGGCGGCCGGCGACCGGTCCGTGCTCGCCGAGCACAACCGGGAGGGCCTGCGGCACGCGGAACGGGCGGGGGACGTGCTGAGCGTGATCAGGATCCGGTCCAACCGGGCGTCGCACCTGGCCGAGGCGGGGGACTACCGGGGAGCGCTCGCCGAGCTGGAGGTCGCGCTGCCGCTGGCCGAGCTGACCGGGTTCACTACCTACCGGGCGTTCTGCCTGAACAACCGGGGCGAGGCCCGACTCGGCCTCGGCCAGCTCGACGAGGCGGTCGCCGACCTCGTCGCCGCCCGCGACATCTTCACCGCGATCTCCTCCAGCCACGCCGCGGTGCCGCTGACCCTGCTCGCCGAGACCTACCGGCAGCGCGGGGACCGGGTGCAGGCCAGAACCGCGTACGAGGAGGCGATCCGGCTCGCCGAGCTGAACGACACCGCGACGCAGCTGGTCCCCGCACTCGCCGGGCTGGCACGGCTGCTGGTCGACGACGAGCCGAACGCCAGCGCCGAGCTGGTGCGCAGGGCACTCTCGTTCGGCGGCGGGTACCCTGCGGTGCTGCTCGCGTCCGCAGCGCTGCACCTGAGCAAGGGGGACGGCGCCGCCGCGAGCGAGGCGGCGGAACAGGCGTCGCGGCTGGCCCGCGAACGCGGCGACCACGCCGGCCTCGCCGAGTCACTGGAGCTGCGGGCGCGGGCGGAGCTGCTGCTCGGGTCGGGCCACGAGCTGTCCTTTGTGGACGAAGCAGCCCGGATCTGGCAGGGGCTGGGCAACATCCGCGCCGAGCGCCGGCTCGCCGCCGTGCGGGCCTCGATGCGGGACGACCAGGAGACCCTCACCATCCAGACCCTCGGCGGGTTCCGGGTGCTGCGGGGCGGTGAGCCGGTGCCGGTCACCGCGTGGCAGTCCCGCAAGGCACGGGACCTGGTCAAGATCCTGGTGGCGCGGCGCGGCAGGCCGGTGTCCAGGGAGGCGTTGATTTCCTTGCTGTGGCCGGGAGAACGGTGCGACCGCGCCGTCGACAAAGCCACGGGCAACCGGCTGTCCGTGGCGCTGTCGACGGCACGGTCGGTGCTCGGCGCCCGGCGCGGCGCGGTGGTCGCGGAGGGCGACACCGTCCGGCTGGACACGGGCGCGGTGACCGTGGACGTGCTGTCGTTCCTGGCCGACGCGCAACGCGGGCTGCGGGAGTGGCGGCAGGAACGGCCGTCGGCGTGGCCGCTGCTGCGCATGGCGGAGGCCACGTACACGGGCGACTTCCTGGAGGAGGACCCGTACGAGGACTGGGCGAGCGAGCTGCGTGAGGAGGCGCGGCTGACCTACGTGCAGGTGGCGATCGTGCTCGCCGGCCACGCCGGCCGGGACGGCGAGCACGTCACGGCCAGCCGCTACTGCCTGCGGGTGCTGGAACGGGACCAGTACAACGAACCAGCCCACCTGGCCCTGGTGCGCGCGCTCGCGGCGGCCGGCAGCCACGGCGAGGCCCGCCGCAGGTACCGGACCTACGTGACCCGCATGGCCGAGATCGACATCGAACCCCGCCCCTTCCCCGACGCCGTGCTCTGA	MLDRPRLSALLSGGDGTRGTRLTTLVAPAGYGKTTLLTGWAGRTRTAWHTCTAEDRELRPALDHLADAVRTALPGLDFTLPPMAGDAHAMSAALCDALGSAELVLVLDDVHVMTERDDSVRLLEGLCRQLPPTARLVLSGRRPPPFAVRRLRDGGQLVELTAGDLAFTADEVAALLTDRLGLCGADFAWLHRVTGGWPIAVRLAGEALRHGHVTDPVRAGQFFDYVATEIVDREPRRTRELVRVAARFPRFRPELLVALGHPYAGETIADLVSRGLFVEALPASPGWFGVLPLVRDFVRTRMPVQDWELRELYDAAARWFSANGHLDAALTALAELDDIDRIQGLLDERADDLLREGGADAVLAAVRLVPPEARHRRTWQLAGEAHQVRGDWSSALDCLNHTVDNGHTSPDVVRRIAWSHYLSGATAEALEVCGRCEPNGADPVAESLLASCAAGARWARGELAECRTAARRAMTLARGSGDDAALAAAHTVHAMLAAAAGDRSVLAEHNREGLRHAERAGDVLSVIRIRSNRASHLAEAGDYRGALAELEVALPLAELTGFTTYRAFCLNNRGEARLGLGQLDEAVADLVAARDIFTAISSSHAAVPLTLLAETYRQRGDRVQARTAYEEAIRLAELNDTATQLVPALAGLARLLVDDEPNASAELVRRALSFGGGYPAVLLASAALHLSKGDGAAASEAAEQASRLARERGDHAGLAESLELRARAELLLGSGHELSFVDEAARIWQGLGNIRAERRLAAVRASMRDDQETLTIQTLGGFRVLRGGEPVPVTAWQSRKARDLVKILVARRGRPVSREALISLLWPGERCDRAVDKATGNRLSVALSTARSVLGARRGAVVAEGDTVRLDTGAVTVDVLSFLADAQRGLREWRQERPSAWPLLRMAEATYTGDFLEEDPYEDWASELREEARLTYVQVAIVLAGHAGRDGEHVTASRYCLRVLERDQYNEPAHLALVRALAAAGSHGEARRRYRTYVTRMAEIDIEPRPFPDAVL	MSIRILLVEDDDHICNTVRAFLAEARYEVDACTDGNEAHTKFYENTYQLVILDIMLPGMNGHELLREFRAQNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMRILLKRVEALLRRSGALAKEFRVGRLTLLPEDFRVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWGYDFDGDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEESL	461.82	gnl|BL_ORD_ID|153|hsp_num:0	141			414	537	vancomycin
